BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Cangene Pages on BioPortfolio:

BioPortfolio - Cangene Corporation
Cangene Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/20404-Cangene_Corpo...

BioPortfolio Biotechnology BioNews : live article
Report 2: Cangene reported the beginning of a clinical trial at Weill Medical College of Cornell University in New York City that will test Cangene's WinRho
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Cangene Corporation - Profile
View the current Cangene Corporation Page on BioPortfolio.com ... Cangene is a world leader in the development , manufacture, and commercialization of ...
http://www.bioportfolio.com/biocorporate/20404-Cangene+Corpo...

Biotechnology News bioterrorism terror anthrax smallpox Search
26 Oct 2009 ... Cangene makes sale to new, international customer ... 22 /CNW/ - Cangene Corporation today announces that it has finalized. ...
http://www.bioportfolio.co.uk/bioterrorism%20terror%20anthra...

BioPortfolio - Cangene Corporation - Profile
View the current Cangene Corporation Page on BioPortfolio.com ... Cangene corporation is a leading Canadian biopharmaceutical company that develops ...
http://www.bioportfolio.com/biocorporate/2393-Cangene%2BCorp...

BioPortfolio - Cangene Corporation news
Cangene Corporation news - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/20404-Cangene+Corpo...

BioPortfolio - BioPortfolio - Cangene Corporation
BioPortfolio - Cangene Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/20404/www.c...

BioPortfolio - Smallpox
Cangene is a world leader in the development , manufacture, and commercialization of specialty ... Cangene has built two decades of success with
the life. ...
http://www.bioportfolio.com/indepth/Smallpox.html...

Competitor Analysis: Human Growth Hormone (hGH)
Cangene. * Critical Pharmaceuticals. * Daewoong Pharmaceutical. * Dainippon Sumitomo Pharma. * Dong-A Pharmaceutical Co. * Eli Lilly ...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitor_Anal...

Bio-equities NASDAQ Biotechnology Stocks
Caliper - Cangene, Click Here. Centene - Cytrx, Click Here. Demegen - Dyax, Click Here. Epoch - Exelixis, Click Here. First Health - Genzyme, Click Here ...
http://www.bioportfolio.com/nasdaq/index.htm...

Results from other life science and pharmaceutical sites:

Cangene Corporation Acquires U.S. Commercialization Rights for ...
20 Oct 2009 ... TORONTO and WINNIPEG, Oct. 19 /CNW/ - Cangene Corporation today announces that it has signed an agreement with its majority shareholder, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159674...

Cangene to host fiscal 2009 conference call on Thursday October 22 ...
20 Oct 2009 ... Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, Oct. 20 /CNW/ - Cangene Corporation today announces that it intends to host a.
http://biz.yahoo.com/cnw/091020/cangene_confrnce_call.html?....

BioSpace - Cangene Corporation News, Search Jobs, Events
20 Oct 2009 ... Cangene Corporation 104 Chancellor Matheson Road Winnipeg Manitoba R3T 5Y3 Canada Phone: 204-275-4200 Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=4200...

Cangene makes sale to new, international customer - Yahoo! Finance
22 Sep 2009 ... Readers are referred to the cautionary notes regarding Forward-looking and.
http://biz.yahoo.com/cnw/090922/cangene_finalize_deal.html?....

CANGENE CORP. - Google Finance
Get the latest on CANGENE CORP. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=ETR:YGE...

Cangene Corporation Acquires Twinstrand Therapeutics - News ...
8 Jul 2009 ... TORONTO and WINNIPEG, July 7 /CNW/ - Cangene Corporation today announces that it has acquired all issued and outstanding shares of privately ...
http://www.biospace.com/news_story.aspx?NewsEntityId=149213...

News: Cangene Buys Exclusive Option for Acute Radiation Syndrome ...
8 May 2009 ... Cangene will exercise its right if it obtains a government contract for development. Bid to BARDA regarding MAXY-G34 protein therapeutic.
http://www.genengnews.com/news/bnitem.aspx?name=54075109...

Cangene Corporation's Human Growth Hormone Drug Submission Is ...
Cangene's rhGH, called Accretropin(TM), was tested for its ability to combat short stature in children with growth hormone deficiency and girls with Turner
...
http://www.biospace.com/news_story.aspx?NewsEntityId=24404...

Maxygen | News |
7 May 2009 ... Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene ... Under the agreement, Cangene has paid Maxygen an up-front fee of $500000. ...
http://www.maxygen.com/newsview.php?listid=318...

Cangene Corporation Opts to Exit European Market with WinRho(R ...
31 Jul 2009 ... TORONTO and WINNIPEG, July 30 /CNW/ - Cangene Corporation today announces that it has withdrawn its Marketing Authorization Applications ...
http://www.biospace.com/news_story.aspx?NewsEntityId=151836...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.